Atherosclerosis: Disease biology affecting the coronary vasculature

被引:112
作者
Libby, Peter
机构
[1] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1016/j.amjcard.2006.09.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The concept of the vulnerable plaque has generated much interest and stimulated a quest to develop diagnostic modalities to identify potentially unstable atherosclerotic plaques. However, accumulating clinical data now suggest that multiple vulnerable plaques coexist in a single coronary tree and that inflammation is a critical determinant of the stability of plaques. Inflammatory mediators, such as cytokines, can influence several biologic processes that regulate stability of the plaque's fibrous cap and its resistance to rupture. Thus, the quest for strategies to identify and target treatment to a single culprit lesion seriously underestimates the complexity of the clinical biology of thrombosis in atherosclerotic arteries. For the optimum management of our patients, we must now also consider the vulnerable artery, the vulnerable arterial bed, and ultimately, the vulnerable patient. Treatment of vulnerable patients should include measures to stabilize plaques and to lessen the thrombotic consequences of plaque disruptions. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:3Q / 9Q
页数:7
相关论文
共 19 条
[1]   Platelet-derived CD40L -: The switch-hitting player of cardiovascular disease [J].
André, P ;
Nannizzi-Alaimo, L ;
Prasad, SK ;
Phillips, DR .
CIRCULATION, 2002, 106 (08) :896-899
[2]   Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina -: Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes [J].
Aukrust, P ;
Müller, F ;
Ueland, T ;
Berget, T ;
Aaser, E ;
Brunsvig, A ;
Solum, NO ;
Forfang, K ;
Froland, SS ;
Gullestad, L .
CIRCULATION, 1999, 100 (06) :614-620
[3]   Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].
Beckman, JA ;
Creager, MA ;
Libby, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581
[4]  
BURING JE, 1992, J MYOCARDIAL ISCHEMI, V4, P19
[5]  
GUPTA S, 2002, TIME 0401
[6]   Comparison of coronary plaque rupture between stable angina and acute myocardial infarction - A three-vessel intravascular ultrasound study in 235 patients [J].
Hong, MK ;
Mintz, GS ;
Lee, CW ;
Kim, YH ;
Lee, SW ;
Song, JM ;
Han, KH ;
Kang, DH ;
Song, JK ;
Kim, JJ ;
Park, SW ;
Park, SJ .
CIRCULATION, 2004, 110 (08) :928-933
[7]   Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) study [J].
Kinlay, S ;
Schwartz, GG ;
Olsson, AG ;
Rifai, N ;
Sasiela, WJ ;
Szarek, M ;
Ganz, P ;
Libby, P .
CIRCULATION, 2004, 110 (04) :386-391
[8]   Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction [J].
Kotani, J ;
Mintz, GS ;
Castagna, MT ;
Pinnow, E ;
Berzingi, CO ;
Bui, AB ;
Pichard, AD ;
Satler, LF ;
Suddath, WO ;
Waksman, R ;
Laird, JR ;
Kent, KM ;
Weissman, NJ .
CIRCULATION, 2003, 107 (23) :2889-2893
[9]   Act local, act global* - Inflammation and the multiplicity of "vulnerable" coronary plaques [J].
Libby, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) :1600-1602
[10]   Inflammation and thrombosis - The clot thickens [J].
Libby, P ;
Simon, DI .
CIRCULATION, 2001, 103 (13) :1718-1720